Article
Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
Antimicrobial agents and chemotherapy - 1 Sept 2018
Charretier Yannick, Diene Seydina M, Baud Damien, Chatellier Sonia, Santiago-Allexant Emmanuelle, van Belkum Alex, Guigon Ghislaine, Schrenzel Jacques
Abstract excerpt
Multidrug-resistant Acinetobacter baumannii infection has recently emerged as a worldwide clinical problem, and colistin is increasingly being used as a last-resort therapy. Despite its favorable bacterial killing, resistance and heteroresistance (HR) to colistin have been described. The purpose of the present study was to investigate the role of the PmrAB regulatory pathway in laboratory-selected mutants...
Topics
- Acinetobacter Infections
- Acinetobacter baumannii
- Anti-Bacterial Agents
- Bacterial Proteins
- Base Sequence
- Colistin
- Drug Resistance, Bacterial
- Humans
- Microbial Sensitivity Tests
- Polymorphism, Single Nucleotide
